20 results
8-K
EX-10.9
CELU
Celularity Inc.
17 Jan 24
Entry into a Material Definitive Agreement
4:14pm
; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter … gender shall include masculine and feminine genders.
(b)The parties hereto agree that any rule of construction to the effect that ambiguities
424B3
CELU
Celularity Inc.
1 Jun 22
Prospectus supplement
4:06pm
on gender diversity since April 2016, a member of the board of directors of Alliance for Regenerative Medicine (ARM) Foundation since 2017 and a co
424B3
eg7ph
3 May 22
Prospectus supplement
4:06pm
POS AM
nbjjzvzyd
1 Apr 22
Prospectus update (post-effective amendment)
9:15pm
424B3
8ha6ah36 ja
12 Aug 21
Prospectus supplement
4:21pm
S-4/A
EX-10.23
x1wpmotz21q8j
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
S-4/A
EX-10.27
lvzx98jjm304c4
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
S-4
EX-10.32
zvhor8befu
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
8-K
EX-2.1
a0auza4s m2z
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
425
EX-2.1
ve6h3r
8 Jan 21
Business combination disclosure
7:02am
S-1
EX-10.5
wvnlou4b1o8jlctpb
26 Apr 19
IPO registration
4:23pm
DRS
EX-10.5
40v2mhq
5 Nov 18
Draft registration statement
12:00am
- Prev
- 1
- Next